![Sourav Kole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sourav Kole
Direttore/Membro del Consiglio presso
Paros Bio, Inc.
Profilo
Sourav Kole is the founder of Xenocor, Inc. (2011).
Current jobs include Director of the Board of Directors at Mindimmune Therapeutics, Inc. (2022), Director at Paros Bio, Inc. (2022), Board Member at Cerevance, Inc. (2022), Board Member at NeuroTherapia, Inc. (2022), Board Member at QurAlis Corp.
(2022), Board Member at Therini Bio, Inc. (2022), and Board Member at Libra Therapeutics, Inc. (2022).
Former jobs include Director at Reservoir Neuroscience, Inc. and Managing Director at Dolby Family Ventures LLC.
Education includes a graduate degree from the University of Utah and an undergraduate degree from The Pennsylvania State University.
Posizioni attive di Sourav Kole
| Società | Posizione | Inizio |
|---|---|---|
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Direttore/Membro del Consiglio | 01/01/2022 |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Direttore/Membro del Consiglio | 01/01/2022 |
Libra Therapeutics, Inc.
 Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Direttore/Membro del Consiglio | 01/01/2022 |
Cerevance, Inc.
 Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Direttore/Membro del Consiglio | 01/01/2022 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Direttore/Membro del Consiglio | 01/01/2022 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Direttore/Membro del Consiglio | 01/01/2022 |
Mindimmune Therapeutics, Inc.
 Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Direttore/Membro del Consiglio | 01/01/2022 |
Precedenti posizioni note di Sourav Kole
| Società | Posizione | Fine |
|---|---|---|
Xenocor, Inc.
 Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Fondatore | 31/12/2015 |
Reservoir Neuroscience, Inc.
 Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Direttore/Membro del Consiglio | - |
| ░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | - |
Formazione di Sourav Kole
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
52
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dolby Family Ventures LLC
 Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures invests in companies located across the globe primarily in the United States. The firm focuses on life sciences and technology sectors such as precision neuroscience, life sciences platforms, climate, digital and aerospace. It participates in pre-seed, seed, early and later stage transactions. The firm also makes follow-on investments. | Finance |
Cerevance, Inc.
Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Mindimmune Therapeutics, Inc.
Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Health Technology |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Health Technology |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Commercial Services |
Reservoir Neuroscience, Inc.
Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Health Technology |
Libra Therapeutics, Inc.
Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Xenocor, Inc.
Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Health Technology |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Health Technology |
